![]() |
Volumn 383, Issue 9914, 2014, Pages 305-306
|
Authors' reply
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CONTRACEPTIVE AGENT;
MEDROXYPROGESTERONE ACETATE;
DRUG DERIVATIVE;
NORETHISTERONE;
CONDOM;
FOLLOW UP;
HORMONAL CONTRACEPTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION RISK;
INTRAUTERINE CONTRACEPTIVE DEVICE;
LETTER;
OBSERVATIONAL STUDY;
POPULATION;
PRIORITY JOURNAL;
RANDOMIZATION;
SAMPLE SIZE;
FEMALE;
METHODOLOGY;
NOTE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
CONTRACEPTIVE AGENTS, FEMALE;
FEMALE;
HIV INFECTIONS;
HUMANS;
MEDROXYPROGESTERONE ACETATE;
NORETHINDRONE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
EID: 84892844932
PISSN: 01406736
EISSN: 1474547X
Source Type: Journal
DOI: 10.1016/s0140-6736(14)60100-8 Document Type: Letter |
Times cited : (4)
|
References (6)
|